Multi-omic characterization of acquired resistance to immune checkpoint inhibitors in patients with metastatic renal cell carcinoma.

被引：1
|
作者：
Saad, Eddy
Labaki, Chris
Miron, Benjamin
Park, Jihye
Bakouny, Ziad
Nassar, Amin
Saliby, Renee Maria
Semaan, Karl
Eid, Marc
Meli, Kevin
Laimon, Yasmin Nabil
Geynisman, Daniel M.
Kokate, Rutika
Braun, David A.
Signoretti, Sabina
Mcgregor, Bradley Alexander
Plimack, Elizabeth R.
Choueiri, Toni K.
Van Allen, Eliezer Mendel
Zibelman, Matthew R.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Fox Chase Canc Ctr, Philadelphia, PA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Harvard Univ, Cambridge, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
[8] Yale Univ, New Haven, CT USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[10] Fox Chase Canc Ctr, Temple Hlth, Philadelphia, PA USA
[11] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-9200; 3282-206-3691-5663-4986; 613-225-3248-9559-9794; 3282-206-3691-2722-5055; 3282-646-4685-2628; 5; 3; 2; 38092-18323; 38092-27449; 38092-23384;
D O I：
10.1200/JCO.2024.42.4_suppl.459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Yuki Nemoto
    Hiroki Ishihara
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Kazunari Tanabe
    Tsunenori Kondo
    Toshio Takagi
    International Urology and Nephrology, 2022, 54 : 47 - 54
  • [2] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Nemoto, Yuki
    Ishihara, Hiroki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (01) : 47 - 54
  • [3] Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
    Chahoud, Jad
    Msaouel, Pavlos
    Ross, Jeremy A.
    McCormick, Barrett Z.
    Bathala, Tharakeswara K.
    Gao, Jianjun
    Horn, Robert
    Xiao, Lianchun
    Sircar, Kanishka
    Campbell, Matthew T.
    Shah, Amishi Y.
    Goswami, Sangeeta
    Zurita, Amado J.
    Jonasch, Eric
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Sharma, Padmanee
    Tannir, Nizar M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 134.e9 - 134.e16
  • [4] Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
    Revati Sharma
    Elif Kadife
    Mark Myers
    George Kannourakis
    Prashanth Prithviraj
    Nuzhat Ahmed
    Journal of Experimental & Clinical Cancer Research, 40
  • [5] Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
    Sharma, Revati
    Kadife, Elif
    Myers, Mark
    Kannourakis, George
    Prithviraj, Prashanth
    Ahmed, Nuzhat
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [6] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [7] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [8] Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Gide, Tuba N.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1260 - 1270
  • [9] Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Lee, Ji Hyun
    Hwang, Soohyun
    Jee, ByulA
    Kim, Jae-Hun
    Lee, Jihwan
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    Kwon, Ghee Young
    Kang, Minyong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [10] Primary resistance (PrR) versus acquired resistance (AcR) to immune checkpoint inhibitors (ICI) in first-line metastatic renal cell carcinoma (mRCC)
    Guida, A.
    Silva, C. Alves Costa
    Colomba-Blameble, E.
    Flippot, R.
    Salviat, F.
    Bracarda, S.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S570 - S570
12345